stockrowAptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) Total debt
AptarGroup, Inc.'s total debt at the end of fiscal 2025 was $1.5B, up 44.5% from $1.0B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.4B. Over the past ten years it has ranged from $777.3M (fiscal 2016) to $1.5B (fiscal 2025) — the current reading is the highest in ten years. AptarGroup, Inc. ranks 12th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.5B | 44.49% |
| FY2024 | $1.0B | (2.96%) |
| FY2023 | $1.1B | (9.73%) |
| FY2022 | $1.2B | 11.65% |
| FY2021 | $1.0B | (6.36%) |
| FY2020 | $1.1B | (2.67%) |
| FY2019 | $1.2B | (3.13%) |
| FY2018 | $1.2B | (5.13%) |
| FY2017 | $1.3B | 61.19% |
| FY2016 | $777.3M | (4.35%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.4B | 0.57% |
| Jun 2026 | $1.4B | 0.16% |
| Mar 2026 | $1.4B | (7.92%) |
| Dec 2025 | $1.5B | 23.52% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BAX Baxter International Inc. compare | $8.6B |
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| TFX Teleflex Incorporated compare | $2.8B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. | $1.4B |
| RGEN Repligen Corporation compare | $555.6M |
| SOLV Solventum Corporation compare | $507.0M |
| ALGN Align Technology, Inc. compare | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ATR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement